Canara Robeco Multi Cap Fund
The scheme is seks to generate long-term capital appreciation through diversifiedinvestments in equity & equity related instruments across large cap, mid cap, and small cap stocks
Growthvine rating: 3/5 — ranked #15 of 34 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹14.17 (as of 2026-10-01) |
|---|
| AUM | ₹5,751 Cr |
|---|
| Expense ratio | 1.57% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Shridatta Bhandwaldar |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| Sharpe ratio | 0.59 |
|---|
| Standard deviation | 15.33% |
|---|
| Max drawdown | −18.79% |
|---|
| Alpha | 3.55 |
|---|
| Beta | 0.9 |
|---|
Over 5 years, captured 94.9% of NIFTY500 Multicap 50:25:25's upside and 91.1% of its downside.
Market cap allocation
| Large cap | 43.3% |
|---|
| Mid cap | 28.5% |
|---|
| Small cap | 28.2% |
|---|
Concentration
| Top 5 holdings | 14.4% |
|---|
| Top 10 holdings | 23.6% |
|---|
| Total holdings | 113 |
|---|
| Index overlap | 39.9% |
|---|
| Active share | 60.1% |
|---|
Top holdings
- HDFC Bank Ltd. — 4.1%
- ICICI Bank Ltd. — 3.7%
- TREPS — 2.7%
- Bharti Airtel Ltd. — 2.3%
- Eternal Limited — 2.3%
- State Bank Of India — 2.1%
- Ajanta Pharma Ltd. — 2.0%
- Infosys Ltd — 1.9%
- TBO TEK LIMITED — 1.9%
- Larsen & Toubro Limited — 1.8%
Top sectors
- Banking & Financial — 21.4%
- Retail — 8.4%
- Pharma & Biotech — 7.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −4.9% | Q4 (Bottom) | #30 of 34 |
| 2025 | 5.1% | Q1 (Top) | #7 of 31 |
| 2024 | 21.5% | Q3 | #16 of 24 |